MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Botulinum toxin treatment of muscle spasms in a case of Satoyoshi syndrome

    I. Bledsoe (San Francisco, CA, USA)

    Objective: To describe improvement in muscle spasms of the jaw and upper limb associated with Satoyoshi syndrome using botulinum toxin injections. Background: Satoyoshi syndrome is…
  • 2019 International Congress

    Plasma membrane Ca2+ Atpase 1 as a candidate to mediate the degeneration of dopaminergic neurons by inflammation in Parkinson’s disease

    B. Erhardt, MS. Marcora, A. Delella Ezcurra, J. Casabona, R. Tarelli, L. Frenkel, P. Bochicchio, D. Bodin, B. Silva, V. Cavaliere Candedo, MI. Farías, C. Ferrari, M. Allo, C. Höcht, A. Chernomoretz, E. Castaño, MC. Leal, F. Pitossi (Capital Federal, Argentina)

    Objective: To identify genes involved in the degeneration of the dopaminergic neurons (DN) of the substantia nigra (SN) by inflammation. Background: Parkinson’s disease (PD) is…
  • 2019 International Congress

    Study on the effect of levodopa administration on serum zinc levels in Parkinson’s disease patients

    H. Matsuyama, K. Matsuura, H. Ishikawa, Y. Hirata, N. Kato, A. Niwa, Y. Narita, H. Tomimoto (Tsu, Japan)

    Objective: Since zinc-chelating action of levodopa has been reported in the past, we measured serum zinc level in patients with Parkinson's disease (PD) at our…
  • 2019 International Congress

    STAT-ON: a Wearable Inertial System to Objectively Evaluate Motor Symptoms in Parkinson’s Disease

    D. Rodriguez-Martin, C. Pérez-López, A. Samà, M. Pié, A. Català, J. Cabestany, A. Rodríguez-Molinero (Vilanova I Geltrú, Spain)

    Objective: We present a wearable inertial system for the evaluation of motor symptoms in Parkinson's Disease. Background: PD is the second neurodegenerative disease affecting to around…
  • 2019 International Congress

    The carotid ultrasonography revealed vagus nerve atrophy of the patients with parkinsonism

    S. Abe, T. Hirato, H. Saiki (Osaka, Japan)

    Objective: This study aims to clarify the compare vagus nerve atrophy with Parkinson’s disease (PD) and other atypical parkinsonism. Background: Although the pathogenesis of the…
  • 2019 International Congress

    Spectrum of parkinsonian phenotypes associated with GCH1 mutation.

    D. Al-Shorafat, A. Shetty, D. Munoz, A. Fasano, A. Lang (Toronto, ON, Canada)

    Objective: To describe the heterogeneity of parkinsonism in patients with GCH1 mutations. Background: Dopa-responsive dystonia (DRD) is an inherited disorder that responds dramatically to levodopa…
  • 2019 International Congress

    Longitudinal assessment of genetic determinants of cognitive decline in Parkinson’s disease

    M. Bakeberg, A. Jefferson, M. Byrnes, S. Ghosh, F. Mastaglia, R. Stell, J. Kenna, S. Walters, M. Hoes, A. Ford, R. Anderton (Nedlands, Australia)

    Objective: This study aimed to investigate the relationships between genetic variants reportedly associated with neurological disease and cognitive decline, in patients with PD over a…
  • 2019 International Congress

    The Dutch Parkinson and Microbiome Study (DUPARM): Gut Microbiome Composition of Treatment-Naïve De Novo Parkinson’s Disease Patients

    J. Boertien, S. Vander Zee, T. van Laar (Groningen, Netherlands)

    Objective: To establish the gut microbiome composition of de novo Parkinson’s disease (PD) patients with no history of dopaminergic medication use. Background: PD is often…
  • 2019 International Congress

    Identifying Incident Cases of Neurodegenerative Parkinsonism in a Large Observational At-Risk Cohort: the PPMI study

    L. Chahine, K. Kieburtz, M. Brumm, C. Caspell-Garcia, C. Coffey, A. Siderowf, D. Weintraub, C. Tanner, T. Foroud, D. Galasko, B. Mollenhauer, T. Simuni, K. Marek (Pittsburgh, PA, USA)

    Objective: To examine the potential of a data-driven approach to identify incident cases of neurodegenerative parkinsonian disorders (PD) in a large observational cohort of individuals…
  • 2019 International Congress

    Attentional Intervention to Improve Cognition and Gait in Parkinson’s Disease: Side of Onset Effects

    A. Cronin-Golomb, O. Barthelemy, A. Marin, B. Davis, S. Alshuaib, T. Ellis, J. Degutis (Boston, MA, USA)

    Objective: To establish whether home-based computerized attentional training would improve cognition, gait, and function in Parkinson’s disease (PD). Background: Impairments in cognition and gait are…
  • « Previous Page
  • 1
  • …
  • 96
  • 97
  • 98
  • 99
  • 100
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley